[{"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88079", "recalling_firm": "Bausch Health Companies, Inc.", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0639-2021", "product_description": "Phytonadione Tablets, 5 mg, 30-count ablets, Rx only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA, NDC 68682-170-30", "product_quantity": "37,797 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20210608", "center_classification_date": "20210623", "termination_date": "20230216", "report_date": "20210630", "code_info": "Lot #:19D013P, Exp Date 07/2021; 20D099P, Exp Date 10/2022"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0604-2021", "product_description": "DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, 5000 mL bags, 2-pack, Rx Only, Fresenius Medical Care NA, Waltham, MA 02451, NDC 49230-0188-50", "product_quantity": "25 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: 20JU01001, Exp. Date February 2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075499"], "brand_name": ["BUTORPHANOL TARTRATE"], "generic_name": ["BUTORPHANOL TARTRATE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0813"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["BUTORPHANOL TARTRATE"], "rxcui": ["886634"], "spl_id": ["c27d5dfe-cde5-a4de-d96e-20ab9b6e6209"], "spl_set_id": ["b8e48063-0b40-ee43-85c1-4ef2de80c404"], "package_ndc": ["60505-0813-1"], "is_original_packager": [true], "unii": ["2L7I72RUHN"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0427-2021", "product_description": "Butorphanol Tartrate Nasal Solution USP 10 mg/mL 2. 5 mL bottles Rx Only NDC 60505-0813-1 Mfg by: Apotex Inc. Toronto, Ontario Canada M9L 1T9", "product_quantity": "38 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "RT7113"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210991"], "brand_name": ["GEMCITABINE"], "generic_name": ["GEMCITABINE HYDROCHLORIDE"], "manufacturer_name": ["Armas Pharmaceuticals Inc."], "product_ndc": ["72485-221"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["GEMCITABINE HYDROCHLORIDE"], "rxcui": ["1720977"], "spl_id": ["52a15e83-e33d-42e7-9270-636b5b59d63b"], "spl_set_id": ["57b80f66-208d-4903-9443-e4c9239e3207"], "package_ndc": ["72485-221-02"], "is_original_packager": [true], "upc": ["0372485221028"], "unii": ["U347PV74IL"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0432-2021", "product_description": "GEMCITABINE INJECTION 200MG/5.26ML; NDC/UPC 72485-221-02; RX; SINGLEDOSE VIAL", "product_quantity": "3 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "7T10050A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019430"], "brand_name": ["EPIPEN"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["49502-500", "49502-501"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["EPINEPHRINE"], "rxcui": ["727316", "727347", "727386", "1870207"], "spl_id": ["81569d26-e9b3-4c1d-ac34-8a4cf5b4a98b"], "spl_set_id": ["7560c201-9246-487c-a13b-6295db04274a"], "package_ndc": ["49502-500-01", "49502-500-02", "49502-500-92", "49502-501-01", "49502-501-02", "49502-501-92"], "is_original_packager": [true], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0528-2021", "product_description": "Epinephrine Injection, USP Auto-Injectors in all strengths, packs and styles Manufactured for Mylan Specialty L.P., Morgantown, WV , NDC: 9502-500-01, 49502-500-02, 49502-500-92, 49502-501-01", "product_quantity": "620 injector", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "0FM544"}, {"status": "Terminated", "city": "Maumee", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["LITE NFOAMY EUCALYPTUS MINT SANITIZING HANDWASH"], "generic_name": ["BENZALKONIUM CHLORIDE"], "manufacturer_name": ["Spartan Chemical Company, Inc."], "product_ndc": ["64009-332"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZALKONIUM CHLORIDE"], "rxcui": ["1020365", "1493162"], "spl_id": ["4094bed1-f0f6-0a67-e063-6394a90ad4e7"], "spl_set_id": ["b464daa7-354a-4a6d-97aa-f77911aa5dc3"], "package_ndc": ["64009-332-75", "64009-332-78", "64009-332-72"], "is_original_packager": [true], "upc": ["0753727261109"], "unii": ["F5UM2KM3W7"]}, "product_type": "Drugs", "event_id": "87633", "recalling_firm": "Spartan Chemical Co Inc", "address_1": "1110 Spartan Dr", "address_2": "N/A", "postal_code": "43537-1725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico; Mexico", "recall_number": "D-0363-2021", "product_description": "Lite'n Foamy Eucalyptus Mint Sanitizing Handwash (Benzalkonium Chloride, 0.13%), Net Contents: 18 oz/ 532 ml per foam pump container, For Institutional and Industrial Use Only, Spartan Chemical Company, Inc., 1110 Spartan Drive, Maumee, OH 43537 USA. UPC 7 53525 26287 8  NDC: 64009-332-72", "product_quantity": "1,200 cases", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20210329", "center_classification_date": "20210430", "termination_date": "20231016", "report_date": "20210421", "code_info": "Lot, expiry: Lot 538307, exp 1/20/2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210560"], "brand_name": ["BROMFENAC OPHTHALMIC SOLUTION 0.09%"], "generic_name": ["BROMFENAC OPHTHALMIC SOLUTION 0.09%"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "product_ndc": ["62332-508"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["BROMFENAC SODIUM"], "rxcui": ["578018"], "spl_id": ["824d37d0-e25f-4df8-be0e-d9a65046fc10"], "spl_set_id": ["225070ee-d862-4d41-84b8-5bd7a8a03fd7"], "package_ndc": ["62332-508-17"], "is_original_packager": [true], "unii": ["8ECV571Y37"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0413-2021", "product_description": "BROMFENAC OPHTHALMIC SOLUTION 0.09% 1.7ML NDC/UPC 62332-508-17; RX; DROPS", "product_quantity": "152 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "AGV009"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077336"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-142", "62756-143"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "spl_id": ["69a60382-bf12-4627-baaf-2e0ac332b443"], "spl_set_id": ["41a8bb80-7b0b-476c-8134-5d161c3239c8"], "package_ndc": ["62756-142-01", "62756-142-02", "62756-143-01"], "is_original_packager": [true], "upc": ["0362756142015", "0362756143012"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "87869", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0372-2021", "product_description": "Metformin HCl Extended-Release Tablets, USP, 500 mg, packaged in 500-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-142-02.", "product_quantity": "50868 bottles", "reason_for_recall": "Presence of foreign substance: identified as activated carbon.", "recall_initiation_date": "20210504", "center_classification_date": "20210507", "termination_date": "20230627", "report_date": "20210519", "code_info": "Lots #: JKX2749A, JKX2803A, JKX2804A, JKX2805A, JKX806A, JKX2945A,JKX2946A, JXK2947A, JKX2948A, JKX2952A, JKX2953A, JKX2954A & JKX3224A, Exp 6/2032; JKX3211A, JKX3212A, Exp 7/2023.", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0454-2021", "product_description": "ATROVENT HFA 17MCG 12.9GM; NDC/UPC 597008717; RX; INHALER MEDICAL INTERNAL - MAY OR MAY NOT BE AEROSOL", "product_quantity": "667 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "200155"}, {"status": "Terminated", "city": "Gulfport", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87742", "recalling_firm": "Grace Healthcare Medical, Inc", "address_1": "1418 31st Ave", "address_2": "N/A", "postal_code": "39501-2746", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0355-2021", "product_description": "Oxygen, Compressed, USP UN 1072, packaged in cylinders labeled as: a) M6 Medical Gas Cylinder, b) C Medical Gas Cylinder; c) D Medical Gas Cylinder; d) E Medical Gas Cylinder; e) M Medical Gas Cylinder; f)  H Medical Gas Cylinder, Rx only, Grace Healthcare 1418 31st Avenue Gulfport, MS 39501 228-863-3331", "product_quantity": "35,838 cylinders", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20210415", "center_classification_date": "20210426", "termination_date": "20221202", "report_date": "20210505", "code_info": "All lots manufactured and distributed 04/01/2019-04/09/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0445-2021", "product_description": "MURO-128 2% 15ML OPTH; NDC/UPC 324208276150; OTC; DROPS", "product_quantity": "64 droptainers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87667", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "N/A", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0333-2021", "product_description": "Itraconazole Capsules, 100 mg, 30-count bottles, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-282-30.", "product_quantity": "Lot #IT119008B - (4,128 Bottles); Lot #IT20001A - (3,984 Bottles); Lot #IT20002B - (4.080 Bottles)", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20210401", "center_classification_date": "20210412", "termination_date": "20220428", "report_date": "20210421", "code_info": "Lot #s: IT119008B, Exp 05/2021; IT120001A, IT120002A, Exp 12/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0554-2021", "product_description": "Chantix (varenicline) Tablets Continuing Month Box Contains: 4 Continuing Weeks (1 mg x 56 tablets) Rx only NDC 0069-0469-03 Distributed by Pfizer Labs Division of Pfizer Inc., NY, NY 10017", "product_quantity": "940 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "EC5910"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206685"], "brand_name": ["ESTRADIOL"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-4619", "0378-4620", "0378-4621", "0378-4622", "0378-4623"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632"], "spl_id": ["e3b94477-b715-40f6-bbbb-fe52a87148dd"], "spl_set_id": ["f4efb0bf-b96f-4e20-a0f2-0806ab92b2d4"], "package_ndc": ["0378-4619-16", "0378-4619-26", "0378-4620-16", "0378-4620-26", "0378-4621-16", "0378-4621-26", "0378-4622-16", "0378-4622-26", "0378-4623-16", "0378-4623-26"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0527-2021", "product_description": "Estradiol Transdermal System, USP 0.1 mg/day (Twice-Weekly) Delivers 0.1 mg/day Rx only NDC 0378-4623-26 Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.", "product_quantity": "72 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3108206"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA204569"], "brand_name": ["BELSOMRA"], "generic_name": ["SUVOREXANT"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "product_ndc": ["0006-0005", "0006-0033", "0006-0325", "0006-0335"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SUVOREXANT"], "rxcui": ["1547104", "1547110", "1547112", "1547114", "1547116", "1547118", "1547573", "1547575"], "spl_id": ["21306af5-e07a-4f8e-8f59-3e0aacc53102"], "spl_set_id": ["e5b72731-1acb-45b7-9c13-290ad12d3951"], "package_ndc": ["0006-0005-10", "0006-0005-30", "0006-0005-13", "0006-0033-10", "0006-0033-30", "0006-0033-13", "0006-0325-10", "0006-0325-30", "0006-0325-13", "0006-0335-10", "0006-0335-30", "0006-0335-13"], "is_original_packager": [true], "nui": ["N0000191000", "N0000190998", "N0000185503", "N0000190114"], "pharm_class_epc": ["Orexin Receptor Antagonist [EPC]"], "pharm_class_moa": ["Orexin Receptor Antagonists [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]"], "unii": ["081L192FO9"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0523-2021", "product_description": "Belsomra (suvorexant) tablets 20 mg Each tablet contains 20 mg suvorexant.  This package contains 30 Tablets in 3 Blister Cards.  Each Blister Card contains 10 Tablets. Rx only NDC 0006-0335-30 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08880, USA", "product_quantity": "299 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1778598"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021879"], "brand_name": ["NUEDEXTA"], "generic_name": ["DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE"], "manufacturer_name": ["Avanir Pharmaceuticals, Inc."], "product_ndc": ["64597-301"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DEXTROMETHORPHAN HYDROBROMIDE", "QUINIDINE SULFATE"], "rxcui": ["1040054", "1040058"], "spl_id": ["545d121c-01b2-4375-9067-52fc8ad23d74"], "spl_set_id": ["484e0918-3442-49dc-8ccf-177f1f3ee9f3"], "package_ndc": ["64597-301-13", "64597-301-60"], "is_original_packager": [true], "unii": ["9D2RTI9KYH", "J13S2394HE"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0442-2021", "product_description": "Nuedexta (dextromethorphan HBr and quinidine sulfate) Capsules 20 mg/10 mg 60 capsules Rx only NDC 64597-301-60 Manufactured by Patheon, Inc. Whitby, ON L1N 5Z5, Canada", "product_quantity": "255 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "CFBFP"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090589"], "brand_name": ["EPINEPHRINE"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-5985", "0093-5986"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "SUBCUTANEOUS"], "substance_name": ["EPINEPHRINE"], "rxcui": ["727316", "1870207"], "spl_id": ["f96bd477-2239-4453-aaa4-e20d16c6e49e"], "spl_set_id": ["04f07f15-55e2-411b-abb8-07eab37f5664"], "package_ndc": ["0093-5986-19", "0093-5986-27", "0093-5985-19", "0093-5985-27"], "is_original_packager": [true], "upc": ["0300935985275", "0300935986272", "009359862703"], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0577-2021", "product_description": "EPINEPHRINE INJECTION USP, 0.3MG (AUTO-INJECTORS) FOR ALLERGIC EMERGENCIES (ANAPHYLAXIS)  2 Auto-Injectors and 1 Trainer, Manufactured for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-5986-27", "product_quantity": "414 boxes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "033J20AA"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0548-2021", "product_description": "Cetirizine Hydrochloride Tablets, 10 mg, 300 Count; NDC/UPC 345802919878; OTC; TABLETS", "product_quantity": "1371 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022254"], "brand_name": ["VIMPAT"], "generic_name": ["LACOSAMIDE"], "manufacturer_name": ["UCB, Inc."], "product_ndc": ["0131-1810", "0131-2477", "0131-2478", "0131-2479", "0131-2480", "0131-5410"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LACOSAMIDE"], "rxcui": ["809974", "809984", "809987", "809990", "809992", "809994", "809996", "809998", "810000", "810002", "993856", "995156"], "spl_id": ["3cd293ae-29eb-ee01-e063-6294a90aff05"], "spl_set_id": ["9e79b42c-38a3-4b2c-a196-a5a1948250e2"], "package_ndc": ["0131-2477-35", "0131-2477-60", "0131-2477-99", "0131-2478-35", "0131-2478-60", "0131-2478-99", "0131-2479-35", "0131-2479-60", "0131-2479-99", "0131-2480-35", "0131-2480-60", "0131-2480-99", "0131-1810-67", "0131-5410-70", "0131-5410-71", "0131-5410-72"], "is_original_packager": [true], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["563KS2PQY5"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0590-2021", "product_description": "VIMPAT  (lacosamide) Tablets, 200mg, 60-count bottle, Rx Only, Manufactured for: UCB, Inc. Smyrna, GA 30080, NDC 0131-2480-35", "product_quantity": "882 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "912064"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022363"], "brand_name": ["LIVALO"], "generic_name": ["PITAVASTATIN CALCIUM"], "manufacturer_name": ["Kowa Pharmaceuticals America, Inc."], "product_ndc": ["66869-104", "66869-204", "66869-404"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PITAVASTATIN CALCIUM"], "rxcui": ["861643", "861646", "861648", "861650", "861652", "861654"], "spl_id": ["8c680b64-3b3d-486d-b64b-a8645d925bba"], "spl_set_id": ["44dcbf97-99ec-427c-ba50-207e0069d6d2"], "package_ndc": ["66869-104-90", "66869-204-90", "66869-204-07", "66869-404-90", "66869-404-07"], "is_original_packager": [true], "upc": ["0366869404909", "0366869104908"], "unii": ["IYD54XEG3W"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0500-2021", "product_description": "Livalo (pitavastatin) tablets 2 mg* Rx Only NdC 66869-204-90 Manufactured under license from: Kowa Company, Limited Tokyo 103-8433 Japan  Tablets Manufactured by: Patheon, Inc. Cincinnati, OH 45237 USA or by Kowa Company, Ltd Nagoya 462-0024 Japan", "product_quantity": "453 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3193479"}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["NP THYROID 15"], "generic_name": ["LEVOTHYROXINE, LIOTHYRONINE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-327"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE", "LIOTHYRONINE"], "rxcui": ["314267", "1855086"], "spl_id": ["f1e67a65-5380-42f8-896d-1d0eda52f6a4"], "spl_set_id": ["a3ff93ad-86ed-4324-ae86-7e7ed3a49db8"], "package_ndc": ["42192-327-01", "42192-327-30", "42192-327-07"], "is_original_packager": [true], "upc": ["0342192327016"], "nui": ["N0000175945", "M0021504", "N0000175946", "M0021977"], "pharm_class_epc": ["l-Thyroxine [EPC]", "l-Triiodothyronine [EPC]"], "pharm_class_cs": ["Thyroxine [CS]", "Triiodothyronine [CS]"], "unii": ["Q51BO43MG4", "06LU7C9H1V"]}, "product_type": "Drugs", "event_id": "87843", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110-B", "address_2": "N/A", "postal_code": "30005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States including Puerto Rico", "recall_number": "D-0395-2021", "product_description": "NP Thyroid 15 Thyroid Tablets, USP 1/4 grain (15 mg), packaged in a) 100-count bottles (NDC 42192-327-01) and b) 7-count bottles (NDC 42192-327-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005", "product_quantity": "a) 66,155 bottles; b) 26,212 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210429", "center_classification_date": "20210524", "termination_date": "20240313", "report_date": "20210602", "code_info": "Lots: a) M327D20-1, M327D20-3 Exp. 03/31/2022, M327H19-3A Exp. 07/31/2021, M327L19-1 Exp. 04/30/2021; b) M327D20-1 Exp. 03/31/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M006"], "brand_name": ["RUGBY BENZOYL PEROXIDE"], "generic_name": ["BENZOYL PEROXIDE"], "manufacturer_name": ["Rugby Laboratories"], "product_ndc": ["0536-1055"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOYL PEROXIDE"], "rxcui": ["308694"], "spl_id": ["2e932297-a9a5-4efb-af0e-bde8fd6892ac"], "spl_set_id": ["de9ac9fe-b6af-45b7-bbf2-70c47f45885b"], "package_ndc": ["0536-1055-56", "0536-1055-25", "0536-1055-57"], "is_original_packager": [true], "unii": ["W9WZN9A0GM"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0513-2021", "product_description": "Acne Medication Benzoyl Peroxide Gel USP, 5% Net Wt 1.5 oz (42.5 g) NDC 0536-1055-56 Distributed by: Rugby Laboratories 31778 Enterprise Drive, Livonia, MI 48150", "product_quantity": "189 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0573-2021", "product_description": "Proair HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation With Dose Counter 200 Metered Inhalation 8,5 g Net Contents Rx only NDC 59310-579-22 Mktd by: Teva Respiratory, LLC Horsham, PA 19044 Mfd by: IVAX Pharmaceuticals Ireland Waterford, Ireland", "product_quantity": "26895 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "DAF02A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065061"], "brand_name": ["CLINDAMYCIN HYDROCHLORIDE"], "generic_name": ["CLINDAMYCIN HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["63304-692", "63304-693"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLINDAMYCIN HYDROCHLORIDE"], "rxcui": ["197518", "284215"], "spl_id": ["339366d4-2060-1c29-e063-6394a90a1cb7"], "spl_set_id": ["1dbd8448-c1e5-46df-8060-50ef82380445"], "package_ndc": ["63304-692-01", "63304-692-05", "63304-692-77", "63304-692-03", "63304-693-16", "63304-693-01", "63304-693-03", "63304-693-05", "63304-693-77", "63304-693-11", "63304-693-62"], "is_original_packager": [true], "upc": ["0363304693010"], "unii": ["T20OQ1YN1W"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0568-2021", "product_description": "CLINDAMYCIN HYDROCHLORIDE CAPSULES, USP,150MG 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc. New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 63304-692-01", "product_quantity": "223 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "AB77104"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078281"], "brand_name": ["PANTOPRAZOLE SODIUM"], "generic_name": ["PANTOPRAZOLE SODIUM"], "manufacturer_name": ["Lannett Company, Inc."], "product_ndc": ["62175-617", "62175-180", "62175-618"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PANTOPRAZOLE SODIUM"], "rxcui": ["251872", "314200"], "spl_id": ["cfbf12d8-f656-4b99-bd2e-fb11bab669e5"], "spl_set_id": ["e7705bf6-e473-4b9c-bb5d-57e26ffe7b97"], "package_ndc": ["62175-617-46", "62175-617-43", "62175-180-46", "62175-180-43", "62175-618-46", "62175-618-43"], "is_original_packager": [true], "upc": ["0362175617460", "0362175180469"], "unii": ["6871619Q5X"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0506-2021", "product_description": "Pantoprazole Sodium Delayed-Release Tablets, USP 20 mg* 90 Tablets Rx Only NDC 62175-180-46 Distributed by: Kremers Urban Pharmaceuticals Inc. Princeton, NJ 08540, USA", "product_quantity": "4 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "20249489A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0569-2021", "product_description": "COREG CR (carvedilol phosphate) Extended Release Capsules, 80 mg, 30-count bottle, Rx Only,/UPC 57664066683", "product_quantity": "133 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "P0978"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206439"], "brand_name": ["NAMZARIC"], "generic_name": ["MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["0456-1207", "0456-1214", "0456-1228", "0456-1221", "0456-1229"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DONEPEZIL HYDROCHLORIDE", "MEMANTINE HYDROCHLORIDE"], "rxcui": ["1599803", "1599805", "1602588", "1602594", "1805420", "1805422", "1805425", "1805427", "1858970", "1858971"], "spl_id": ["5986388c-0e44-4daf-b32d-7b133312b6c9"], "spl_set_id": ["90fedc32-19e5-480c-afc6-f35a5cf4b9aa"], "package_ndc": ["0456-1214-63", "0456-1214-90", "0456-1214-30", "0456-1214-11", "0456-1228-63", "0456-1228-90", "0456-1228-30", "0456-1228-11", "0456-1207-30", "0456-1221-30", "0456-1229-29", "0456-1229-04"], "is_original_packager": [true], "upc": ["0304561221301", "0304561207305"], "unii": ["JY0WD0UA60", "3O2T2PJ89D"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0418-2021", "product_description": "Namzaric (memantine HCl extended release and donepezil HCl) capsules 14 mg/10 mg per capsule 30 capsules Rx Only NDC 0456-1214-30 Distributed by Forest Pharmaceuticals, Inc. Subsidiary of Forest Laboratories, LLC.", "product_quantity": "659 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "W04815"}]